Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Circulation. 1977;55:74-78

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beller, G. A.
Right arrow Articles by Smith, T. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beller, G. A.
Right arrow Articles by Smith, T. W.

Circulation, Vol 55, 74-78, Copyright © 1977 by American Heart Association

ARTICLES

Localization of radiolabeled cardiac myosin-specific antibody in myocardial infarcts. Comparison with technetium-99m stannous pyrophosphate

GA Beller, BA Khaw, E Haber and TW Smith

The myocardial uptake of radioiodinated (Fab')2 fragments of antimyosin antibody [125I-(Fab')2] was compared with simultaneously administered 99mTc-pyrophosphate (Tc-PYP) in dogs undergoing coronary occlusion for 24 (N=6) or 72 hours (N=5). Relative concentrations of both agents in normal and infarcted myocardium were related to regional blood flow as determined by distribution of 55Sr-labeled microspheres in the same animals. There was an inverse exponential relationship between 125I- (Fab')2 localization and regional blood flow in 24 hr (r=-0.64) and 72 hr (r=-0.80) occluded animals. The greatest uptake of 125I-(Fab')2 was observed in subendocardial layers of the center of the infarct where regional flow was most severely impaired (1-10% of normal flow). Maximal localization of Tc-PYP was observed in subepicardial layers in samples from the periphery of the infarct where flow was only moderately reduced (31-50% of normal). Differences in distribution of these two agents in ischemic myocardium are probably related to differences in kinetics of exit from the blood pool.


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
F. Al-Ejeh, J. M. Darby, and M. P. Brown
The La Autoantigen Is a Malignancy-Associated Cell Death Target That Is Induced by DNA-Damaging Drugs
Clin. Cancer Res., September 15, 2007; 13(18): 5509s - 5518s.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
F. Al-Ejeh, J. M. Darby, K. Pensa, K. R. Diener, J. D. Hayball, and M. P. Brown
In vivo Targeting of Dead Tumor Cells in a Murine Tumor Model Using a Monoclonal Antibody Specific for the La Autoantigen
Clin. Cancer Res., September 15, 2007; 13(18): 5519s - 5527s.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J. A. C. Lima, R. M. Judd, A. Bazille, S. P. Schulman, E. Atalar, and E. A. Zerhouni
Regional Heterogeneity of Human Myocardial Infarcts Demonstrated by Contrast-Enhanced MRI : Potential Mechanisms
Circulation, September 1, 1995; 92(5): 1117 - 1125.
[Abstract] [Full Text]

Home page
 ScienceHome page
B. Khaw, F. Fallon, H. Strauss, and E Haber
Myocardial infarct imaging of antibodies to canine cardiac myosin with indium-111-diethylenetriamine pentaacetic acid
Science, July 11, 1980; 209(4453): 295 - 297.
[Abstract] [PDF]


Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 1977 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.